Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived COL1A1 and facilitates ovarian cancer metastasis

被引:59
作者
Li, Mingyue [1 ]
Wang, Jiaying [1 ]
Wang, Conghui [1 ]
Xia, Lili [2 ]
Xu, Junfen [2 ]
Xie, Xing [2 ]
Lu, Weiguo [2 ]
机构
[1] Zhejiang Univ, Womens Hosp, Sch Med, Womens Reprod Hlth Lab Zhejiang Prov, Hangzhou 310006, Peoples R China
[2] Zhejiang Univ, Womens Hosp, Sch Med, Dept Gynecol Oncol, Hangzhou 310006, Peoples R China
基金
中国国家自然科学基金;
关键词
Ovarian cancer metastasis; Tumor microenvironment; Ascites; Fibroblast; COL1A1; Integrin beta 1; VASCULAR-PERMEABILITY FACTOR; EXTRACELLULAR-MATRIX; PROMOTES METASTASIS; GROWTH; COLLAGEN; FIBRINOGEN; PROGRESSION; ASCITES; BIOSYNTHESIS; VEGF;
D O I
10.1016/j.yexcr.2020.112153
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Wide peritoneal metastasis is the cause of the highest lethality of ovarian cancer in gynecologic malignancies. Ascites play a key role in ovarian cancer metastasis, but involved mechanism is uncertain. Here, we performed a quantitative proteomics of ascites, and found that collagen type I alpha 1 (COL1A1) was notably elevated in ascites from epithelial ovarian cancer patients compared to normal peritoneal fluids, and verified that elevated COL1A1 was mainly originated from fibroblasts. COL1A1 promoted migration and invasion of ovarian cancer cells, but such effects were partially eliminated by COL1A1 antibodies. Intraperitoneally injected COL1A1 accelerated intraperitoneal metastasis of ovarian cancer xenograft in NOD/SCID mice. Further, COL1A1 activated downstream AKT phosphorylation by binding to membrane surface receptor integrin beta 1 (ITGB1). Knockdown or blockage of ITGB1 reversed COL1A1 enhanced migration and invasion in ovarian cancer cells. Conversely, ovarian cancer ascites and fibrinogen promoted fibroblasts to secrete COL1A1. Elevated fibrinogen in ascites might be associated with increased vascular permeability induced by ovarian cancer. Our findings suggest that microenvironment remodeled by tumor cells and stromal cells promotes fibroblasts to secrete COL1A1 and facilitates the metastasis of ovarian cancer, which may provide a new approach for ovarian cancer therapeutics.
引用
收藏
页数:13
相关论文
共 41 条
[1]   Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research [J].
Ahmed, Nuzhat ;
Stenvers, Kaye L. .
FRONTIERS IN ONCOLOGY, 2013, 3
[2]  
[Anonymous], 2014, ELIFE
[3]   Pattern and prognostic factors in patients with malignant ascites: a retrospective study [J].
Ayantunde, A. A. ;
Parsons, S. L. .
ANNALS OF ONCOLOGY, 2007, 18 (05) :945-949
[4]   Regulation of vascular permeability by vascular endothelial growth factors [J].
Bates, DO ;
Harper, SJ .
VASCULAR PHARMACOLOGY, 2002, 39 (4-5) :225-237
[5]   Remodelling the extracellular matrix in development and disease [J].
Bonnans, Caroline ;
Chou, Jonathan ;
Werb, Zena .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (12) :786-801
[6]   Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread [J].
C. Pablo Carmignani ;
Tessa A. Sugarbaker ;
Christina M. Bromley ;
Paul H. Sugarbaker .
Cancer and Metastasis Reviews, 2003, 22 (4) :465-472
[7]   In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling [J].
Casar, B. ;
Rimann, I. ;
Kato, H. ;
Shattil, S. J. ;
Quigley, J. P. ;
Deryugina, E. I. .
ONCOGENE, 2014, 33 (02) :255-268
[8]   Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis [J].
Erdogan, Begum ;
Webb, Donna J. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2017, 45 :229-236
[9]   Hypoxia and the extracellular matrix: drivers of tumour metastasis [J].
Gilkes, Daniele M. ;
Semenza, Gregg L. ;
Wirtz, Denis .
NATURE REVIEWS CANCER, 2014, 14 (06) :430-439
[10]   Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis [J].
Hagemann, Thorsten ;
Robinson, Stephen C. ;
Thompson, Richard G. ;
Charles, Kellie ;
Kulbe, Hagen ;
Balkwill, Frances R. .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (07) :1993-2002